<Anchor>
Russia has applied to the European Union for emergency use of the Russian-made corona vaccine, which is being considered for domestic introduction.
At the same time, negotiations are being held to include domestic vaccines in the international joint vaccine project.
Reporter Kim Kyung-hee reports.
<Reporter> An
application for emergency use of'Sputnik V', a Corona 19 vaccine developed by Russia itself, has been submitted to the European Medicines Agency.
If approved by the European Medicines Agency and recommended for urgent use, the'Sputnik V'vaccine can be supplied to European countries in unison.
There are three types of Corona 19 vaccines that have been approved by the European Union so far: Pfizer and Modena and AstraZeneca vaccines.
Russia is also negotiating to include domestic vaccines on the list of vaccines for'Covax Facility', a vaccine joint procurement project led by the World Health Organization and WHO.
23 countries, including Pakistan and Mongolia, have already approved the emergency use of Sputnik V without their own clinical trials.
Sputnik V is the world's first COVID-19 vaccine approved by Russia in August last year, and its efficacy and safety were controversial as it was approved before the final clinical trial.
However, the evaluation of the vaccine is changing positively with the recent publication of a phase 3 result that the immune effect reaches 91.6% in the prestigious medical journal Lancet.
Germany and France, which are experiencing a shortage of vaccines, have previously announced that they will positively review the introduction of Russian vaccines.